"At Acuity Pharmaceuticals we faced many challenges back in 2003. Five years later, we can view our scientific and financial successes with the benefit of hindsight to seek the contributing factors to that success. BioAdvance was one of the first companies we presented our company to. We received quick feedback and then were involved in a thorough diligence process which gave us more input and encouragement. At that early juncture, BioAdvance decided to invest, yet it was far more than money that made the difference. The BioAdvance team provided contacts and an effective sounding board for our development during those formative years."

Dale Pfost
Former CEO
Acuity Pharmaceuticals
Philadelphia, PA

Newsroom >> BioAdvance and Portfolio News Coverage

BioAdvance and Portfolio News Coverage

2010

2010

July 20, 2010 - Bio World
Is Venture Riding the Summer Roller Coaster?

> View Article

July 9, 2010 - Blooomberg
Expert: Avid could launch Alzheimer's agent ahead of GE, Bayer

> View Article

June 23, 2010 - New York TImes
Promise Seen for Detecting Alzheimer's (Avid Radiopharmaceuticals)

> View Article

June 2, 2010
QR Pharma Receives Funding

> View Article

May 26, 2010
Entrepreneur OnRamp Helps Dozens of New Life Science Focused Startups

> View Article

May 24, 2010
Immunome Completes Financing to Advance Infectious Disease Drug Discovery

> View Article

March 6, 2010 - Biotech Billboard
On the Brink of Generic Biotech Drugs, What’s the Cost to Innovation?

> View Article

March 6, 2010 - Biotechbillboard.com
Tech Investment Trends: Private Equity Bullish on Biotech, Clean Tech and Social Media

> View Article

March 5, 2010 - Philadelphia Business Journal
Midsize pharma firms show big appetite for deals

> View Article

February 10, 2010 - Triangle Business Journal
Life Science Venture Capital Funding Overcomes Recent Loss, Outpaces Other Sectors According to PWC

> View Article

February 8, 2010
Biggest Challenges Facing Biotechs

> View Article

LOGIN

PASSWORD